利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

30 条记录 (耗时 0.066 秒)

    Inhibitors of glutaminyl cyclase
    6.
    发明授权
    Inhibitors of glutaminyl cyclase 有权
    谷氨酰胺环化酶抑制剂

    公开(公告)号：US08420684B2

    公开(公告)日：2013-04-16

    申请号：US11937146

    申请日：2007-11-08

    申请人： Michael Thormann ,  Michael Altmstetter ,  Andreas Treml ,  Ulrich Heiser ,  Mirko Buchholz ,  Andre J. Niestroj

    发明人： Michael Thormann ,  Michael Altmstetter ,  Andreas Treml ,  Ulrich Heiser ,  Mirko Buchholz ,  Andre J. Niestroj

    IPC分类号： A61K31/4166 ,  A61K31/4178 ,  C07D233/70 ,  C07D233/88

    CPC分类号： C07D405/14 ,  C07D401/14 ,  C07D403/04 ,  C07D403/06 ,  C07D403/14 ,  C07D409/14 ,  C07D417/14

    摘要： The present invention relates to compounds of formula (I), combinations and uses thereof for disease therapy, or a pharmaceutically acceptable salt, solvate or polymorph thereof, including all tautomers and stereoisomers thereof wherein R1 represents heteroaryl; -carbocyclyl-heteroaryl; -alkenylheteroaryl or -alkylheteroaryl; R2 represents alkyl which may optionally be substituted by hydroxy; carbocyclyl, which may optionally be substituted by one or more groups selected from alkyl and hydroxy; aryl; -aryl-heteroaryl; -heteroaryl-aryl; -aryl-heterocyclyl; H; heteroaryl; or heterocyclyl, which may optionally be substituted by one or more groups selected from alkyl oxo and hydroxy; R3 represents alkyl which may optionally be substituted by one of more groups selected from alkoxy, amine, hydroxy and —C(O)Oalkyl; carbocyclyl, which may optionally be substituted by one or more groups selected from alkyl haloalkyl, alkoxy, amine, hydroxy and —C(O)Oalkyl; -alkyl-aryl; -alkyl(aryl)2; -alkyl-heteroaryl; -alkyl(heteroaryl)2; -alkyl(heteroaryl)(aryl); -aryl-O-aryl; aryl; heterocyclyl, -alkyl-C(O)-heterocyclyl, -alkyl-heterocyclyl, -alkyl-C(O)—NR5-heterocyclyl or -alkyl(heterocyclyl)2 in any of which groups heterocyclyl may be optionally substituted by one or more groups selected from alkyl hydroxy and oxo; -heteroaryl; or -hydroxyalkylaryl; R4 represents H or C1-3 alkyl; R5 represents H or C1-3 alkyl; and X represents O or S.

    摘要翻译： 本发明涉及式（I）化合物，其用于疾病治疗的组合和用途，或其药学上可接受的盐，溶剂化物或多晶型物，包括其所有互变异构体和立体异构体，其中R 1表示杂芳基; 羧基 - 杂芳基; - 烯基杂芳基或 - 烷基杂芳基; R 2表示可任意被羟基取代的烷基; 碳环基，其可任选被一个或多个选自烷基和羟基的基团取代; 芳基; 芳基 - 杂芳基; - 杂芳基 - 芳基; 芳基 - 杂环基 H; 杂芳基; 或杂环基，其可任选被一个或多个选自烷基氧基和羟基的基团取代; R3表示可以任选被选自烷氧基，胺，羟基和-C（O）O烷基的更多个基团之一取代的烷基; 碳环基，其可任选被一个或多个选自烷基卤代烷基，烷氧基，胺，羟基和-C（O）O烷基的基团取代; - 烷基 - 芳基; - 烷基（芳基）2; - 烷基 - 杂芳基 - 烷基（杂芳基）2; - 烷基（杂芳基）（芳基）; 芳基-O-芳基; 芳基; 杂环基， - 烷基-C（O） - 杂环基， - 烷基 - 杂环基， - 烷基-C（O）-NR5 - 杂环基或 - 烷基（杂环基）2，其中任意一个组杂环基可以任选被一个或多个基团取代 选自烷基羟基和氧代; 杂芳基 或 - 羟基烷基芳基; R 4表示H或C 1-3烷基; R5表示H或C1-3烷基; X表示O或S.

    Inhibitors of glutaminyl cyclase
    9.
    发明授权
    Inhibitors of glutaminyl cyclase 有权
    谷氨酰胺环化酶抑制剂

    公开(公告)号：US08278345B2

    公开(公告)日：2012-10-02

    申请号：US11937149

    申请日：2007-11-08

    申请人： Michael Thormann ,  Michael Altmstetter ,  Andreas Treml ,  Ulrich Heiser ,  Mirko Buchholz ,  Andre J. Niestroj

    发明人： Michael Thormann ,  Michael Altmstetter ,  Andreas Treml ,  Ulrich Heiser ,  Mirko Buchholz ,  Andre J. Niestroj

    IPC分类号： A61K31/4025 ,  A61K31/4178 ,  C07D207/00 ,  C07D403/06 ,  C07D233/56

    CPC分类号： C07D403/06 ,  C07D401/14 ,  C07D403/04 ,  C07D403/14 ,  C07D405/14 ,  C07D409/14 ,  C07D413/14 ,  C07D417/04

    摘要： The present invention relates to compounds of formula (I), combinations and uses thereof for disease therapy, R1 represents heteroaryl, -carbocyclyl-heteroaryl, -alkenylheteroaryl or -alkylheteroaryl; R2 represents hydrogen; halogen; alkenyl; alkynyl; -alkenylaryl; -alkenylheteroaryl; alkyl, which may optionally be substituted by one or more groups selected from halogen, hydroxyl, alkoxy-, -thioalkyl, —C(O)OH and —C(O)O-alkyl; carbocyclyl, which may optionally be substituted by one or more groups selected from alkyl, halogen, hydroxyl, alkoxy-, -thioalkyl, —C(O)OH and —C(O)O-alkyl; -alkylcarbocyclyl; -alkylheterocyclyl; aryl; heteroaryl; heterocyclyl; -alkylaryl; -alkyl(aryl)2, -alkylheteroaryl; -aryl-heteroaryl; -heterocyclyl-aryl; -aryl-aryl; -heteroaryl-aryl; -heteroaryl-heteroaryl, and —C(O)R4; R3 represents halogen; alkyl optionally substituted by one or more groups selected from halogen, hydroxyl, alkoxy, thioalkyl, —C(O)OH and —C(O)O-alkyl; aryl; heteroaryl; —C(O)R5; R4 and R5 independently represent alkyl, aryl, heteroaryl, -alkylaryl, -alkylheteroaryl, carbocyclyl, heterocyclyl, -alkylcarbocyclyl and -alkylheterocyclyl, with the proviso that, when R1 is imidazolyl, -carbocyclyl-imidazolyl, -alkenyl-imidazolyl or -alkyl-imidazolyl, then R3 may not be —C(O)R5.

    摘要翻译： 本发明涉及式（I）化合物，其用于疾病治疗的组合和用途，R 1表示杂芳基， - 碳环基 - 杂芳基， - 烯基杂芳基或 - 烷基杂芳基; R2表示氢; 卤素; 烯基; 炔基; - 烯基芳基; 烯基杂芳基 烷基，其可任选被一个或多个选自卤素，羟基，烷氧基 - ， - 硫代烷基，-C（O）OH和-C（O）O-烷基的基团取代; 碳环基，其可任选被一个或多个选自烷基，卤素，羟基，烷氧基 - ， - 硫代烷基，-C（O）OH和-C（O）O-烷基的基团取代; - 烷基羧基 - 烷基杂环基 芳基; 杂芳基; 杂环基 - 烷基芳基; - 烷基（芳基）2， - 烷基杂芳基; 芳基 - 杂芳基; - 杂环基 - 芳基; 芳基 - 芳基; - 杂芳基 - 芳基; - 杂芳基 - 杂芳基和-C（O）R 4; R3表示卤素; 任选被一个或多个选自卤素，羟基，烷氧基，硫代烷基，-C（O）OH和-C（O）O-烷基的基团取代的烷基; 芳基; 杂芳基; -C（O）R 5; R 4和R 5独立地表示烷基，芳基，杂芳基， - 烷基芳基， - 烷基杂芳基，碳环基，杂环基， - 烷基碳环基和 - 烷基杂环基，条件是当R 1是咪唑基， - 环保基 - 咪唑基， - 烯基 - 咪唑基或 - 咪唑基，那么R 3可以不是-C（O）R 5。

    Novel Inhibitors of Glutaminyl Cyclase
    10.
    发明申请
    Novel Inhibitors of Glutaminyl Cyclase 有权
    新型抑制谷氨酰胺环化酶

    公开(公告)号：US20080221086A1

    公开(公告)日：2008-09-11

    申请号：US11937146

    申请日：2007-11-08

    申请人： Michael Thormann ,  Michael Altmstetter ,  Andreas Treml ,  Ulrich Heiser ,  Mirko Buchholz ,  Andre J. Niestroj

    发明人： Michael Thormann ,  Michael Altmstetter ,  Andreas Treml ,  Ulrich Heiser ,  Mirko Buchholz ,  Andre J. Niestroj

    IPC分类号： C07D403/02 ,  C07D401/14 ,  C07D403/14 ,  C07D411/14 ,  A61K31/4178 ,  A61K31/4725 ,  A61K31/5377 ,  A61K31/551 ,  A61P31/00 ,  A61P37/00 ,  A61P35/00 ,  A61P25/00 ,  A61K31/541 ,  A61K31/495 ,  A61K31/445 ,  C07D413/14 ,  C07D405/00 ,  C07D401/02

    CPC分类号： C07D405/14 ,  C07D401/14 ,  C07D403/04 ,  C07D403/06 ,  C07D403/14 ,  C07D409/14 ,  C07D417/14

    摘要： The present invention relates to compounds of formula (I), combinations and uses thereof for disease therapy, or a pharmaceutically acceptable salt, solvate or polymorph thereof, including all tautomers and stereoisomers thereof wherein R1 represents heteroaryl; -carbocyclyl-heteroaryl; -alkenylheteroaryl or -alkylheteroaryl; R2 represents alkyl which may optionally be substituted by hydroxy; carbocyclyl, which may optionally be substituted by one or more groups selected from alkyl and hydroxy; aryl; -aryl-heteroaryl; -heteroaryl-aryl; -aryl-heterocyclyl; H; heteroaryl; or heterocyclyl, which may optionally be substituted by one or more groups selected from alkyl oxo and hydroxy; R3 represents alkyl which may optionally be substituted by one of more groups selected from alkoxy, amine, hydroxy and —C(O)Oalkyl; carbocyclyl, which may optionally be substituted by one or more groups selected from alkyl haloalkyl, alkoxy, amine, hydroxy and —C(O)Oalkyl; -alkyl-aryl; -alkyl(aryl)2; -alkyl-heteroaryl; -alkyl(heteroaryl)2; -alkyl(heteroaryl)(aryl); -aryl-O-aryl; aryl; heterocyclyl, -alkyl-C(O)-heterocyclyl, -alkyl-heterocyclyl, -alkyl-C(O)—NR5-heterocyclyl or -alkyl(heterocyclyl)2 in any of which groups heterocyclyl may be optionally substituted by one or more groups selected from alkyl hydroxy and oxo; -heteroaryl; or -hydroxyalkylaryl; R4 represents H or C1-3 alkyl; R5 represents H or C1-3 alkyl; and X represents O or S.

    摘要翻译： 本发明涉及式（I）化合物，其用于疾病治疗的组合和用途，或其药学上可接受的盐，溶剂化物或多晶型物，包括所有互变异构体和立体异构体，其中R 1表示杂芳基; 羧基 - 杂芳基; - 烯基杂芳基或 - 烷基杂芳基; R 2表示可任选被羟基取代的烷基; 碳环基，其可任选被一个或多个选自烷基和羟基的基团取代; 芳基; 芳基 - 杂芳基; - 杂芳基 - 芳基; 芳基 - 杂环基 H; 杂芳基; 或杂环基，其可任选被一个或多个选自烷基氧基和羟基的基团取代; R 3表示可任意被选自烷氧基，胺，羟基和-C（O）O烷基中的一个以上基团取代的烷基; 碳环基，其可任选被一个或多个选自烷基卤代烷基，烷氧基，胺，羟基和-C（O）O烷基的基团取代; - 烷基 - 芳基; - 烷基（芳基）2。 - 烷基 - 杂芳基; - 烷基（杂芳基）2 - - 烷基（杂芳基）（芳基）; 芳基-O-芳基; 芳基; 杂环基， - 烷基-C（O） - 杂环基， - 烷基 - 杂环基， - 烷基-C（O）-NR 5 - 杂环基或 - 烷基（杂环基） 在其中任何一个基团中，杂环基可以任选被一个或多个选自烷基羟基和氧代基团取代; 杂芳基 或 - 羟基烷基芳基; R 4表示H或C 1-3烷基; R 5表示H或C 1-3烷基; X表示O或S.